PHYSIOLOGICAL INDIRECT RESPONSE MODELS CHARACTERIZE DIVERSE TYPES OF PHARMACODYNAMIC EFFECTS

被引:273
作者
JUSKO, WJ
KO, HC
机构
[1] Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo
关键词
D O I
10.1038/clpt.1994.155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A family of four basic physiologic indirect response models has been proposed to account for the pharmacodynamics of drugs that act by way of inhibition or stimulation of the production or loss of endogenous substances or mediators. Such models were applied previously to account for the anticoagulant effects of warfarin, adrenal suppression by corticosteroids, cell trafficking effects of corticosteroids, antipyretic effects of ibuprofen, and aldose reductase inhibition. Additional responses that can be readily characterized with such models include muscular contraction from pyridostigmine, diuresis from furosemide, bronchodilation from terbutaline, prolactin secretion after cimetidine, and potassium suppression by terbutaline. This report shows that indirect response models, rather than ''link'' or ''hypothetical effect compartment'' models, may be more appropriate for diverse drugs when time lags exist between plasma or biophase drug concentrations and the time course of pharmacodynamic responses.
引用
收藏
页码:406 / 419
页数:14
相关论文
共 38 条
[21]   GENDER-BASED EFFECTS ON METHYLPREDNISOLONE PHARMACOKINETICS AND PHARMACODYNAMICS [J].
LEW, KH ;
LUDWIG, EA ;
MILAD, MA ;
DONOVAN, K ;
MIDDLETON, E ;
FERRY, JJ ;
JUSKO, WJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (04) :402-414
[22]   INHIBITION OF RAT SPLENOCYTE PROLIFERATION WITH METHYLPREDNISOLONE - IN-VIVO EFFECT OF LIPOSOMAL FORMULATION [J].
MISHINA, EV ;
JUSKO, WJ .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :848-854
[23]  
NAGASHIMA R, 1969, CLIN PHARMACOL THER, V10, P22
[24]  
Nakayama T, 1989, Prog Clin Biol Res, V290, P265
[25]   2ND GENERATION MODEL FOR PREDNISOLONE PHARMACODYNAMICS IN THE RAT [J].
NICHOLS, AI ;
BOUDINOT, FD ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1989, 17 (02) :209-227
[26]   RENAL TUBULAR SECRETION AND EFFECTS OF FUROSEMIDE [J].
ODLIND, B ;
BEERMANN, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :784-790
[27]   PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF TERBUTALINE BRONCHODILATION IN ASTHMA [J].
OOSTERHUIS, B ;
BRAAT, MCP ;
ROOS, CM ;
WEMER, J ;
VANBOXTEL, CJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) :469-475
[28]   APPLICABILITY OF RED-BLOOD-CELL SORBITOL MEASUREMENTS TO MONITOR THE CLINICAL ACTIVITY OF SORBINIL [J].
PETERSON, MJ ;
PAGE, MG ;
JUST, LJ ;
ALDINGER, CE ;
MALONE, JI .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04) :93-95
[29]  
POPA V, 1986, CLIN CHEST MED, V7, P313
[30]  
ROHDEWALD P, 1989, AGENTS ACTIONS, V17, P290